// App-Quantinova.ai

: Incorporation of Clinical Information to Decipher Driver Mutations in Myeloproliferative Neoplasms

Researchers

Presenter

  • Murtadha K. Al-Khabori

Principal Investigators

  • Shoaib Al-Zadjali

  • Mohamed Al-Rawahi

  • Iman Al Noumani

  • Khalil Al Farsi

  • Salam Al-Kindi

  • Mohamed Al Huneini

  • Al Lamki Sulayma

  • Mahdiya Al-Belushi

  • Khalid Al Hashmi

  • Muna Al Tarshi

  • Muhanna Almusalhi

Medical Centers

  • Sultan Qaboos University Hospital, Muscat, Oman

  • Oman Medical Speciality board, Al-Athaiba, Oman

  • Department of Microbiology & Immunology, Sultan Qaboos University Hospital, College of Medicine and Health Sciences, Muscat, Oman

  • Department of Haematology, Sultan Qaboos University Hospital, Muscat, Oman

  • Sultan Qaboos University Hospital, Muscat, Oman

  • Department of Hematology, Royal Hospital, muscat, Oman

  • Royal Hospital, Muscat, Oman

  • Armed Forces Hospital, Al-Khoud, Oman

Locations

  • Oman

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Myeloid neoplasms

  • Venous thrombosis

Biomarkers

  • CCAAT enhancer binding protein alpha

  • Colony stimulating factor 3 receptor

  • DNA methyltransferase 3 alpha

  • E3 ubiquitin-protein ligase CBL

  • Enhancer of zeste homolog 2

  • Isocitrate dehydrogenase 2

  • Lactate

  • Lactate dehydrogenase

  • Tet methylcytosine dioxygenase 2

  • White Blood Cell

Drug/Treatment

  • Erythropoietin

  • EZH2

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved